Cargando…

Impact of Medicare prescription drug (Part D) coverage expansion on utilisation and financial burden of benzodiazepines among older adults: an interrupted time series analysis

OBJECTIVE: Benzodiazepines were excluded from Medicare Part D coverage since its introduction in 2006. Part D expanded coverage for benzodiazepines in 2013. The objective was to examine the impact of Medicare Part D coverage expansion on the utilisation and financial burden of benzodiazepines in old...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Minghui, Yuan, Jing, Dezfuli, Chelsea, Lu, Z Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Health Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679099/ https://www.ncbi.nlm.nih.gov/pubmed/34911718 http://dx.doi.org/10.1136/bmjopen-2021-053717

Ejemplares similares

Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries
por: Maust, Donovan T., et al.
Publicado: (2020)

Effect of reimbursement restriction policy on the use of benzodiazepines in the Netherlands: an interrupted time series analysis
por: Stoker, Lennart Jan, et al.
Publicado: (2019)

RELATIONSHIP BETWEEN FINANCIAL IMPACT AND COVERAGE OF DRUGS IN AUSTRALIA
por: Mauskopf, Josephine, et al.
Publicado: (2013)

Impact of abolishing prescription fees in Scotland on hospital admissions and prescribed medicines: an interrupted time series evaluation
por: Williams, Andrew James, et al.
Publicado: (2018)

The influence of Medicare Part D on the list pricing of brand drugs
por: Ippolito, Benedic N., et al.
Publicado: (2023)

Variation in Estimated Medicare Prescription Drug Plan Costs and Affordability for Beneficiaries Living in Different States
por: Davis, Matthew M., et al.
Publicado: (2007)

Pooling financial resources for universal health coverage: options for reform
por: Mathauer, Inke, et al.
Publicado: (2020)

Prescription Drug Expenditures, Financial Burden, and Health Plan Satisfaction Among Medicare Beneficiaries
por: Curtiss, Frederic R.
Publicado: (2003)

Prescription Drug Coverage and Spending for Medicare Beneficiaries
por: Poisal, John A., et al.
Publicado: (1999)

Reforms for financial protection schemes towards universal health coverage, Senegal
por: Daff, Bocar Mamadou, et al.
Publicado: (2020)

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis
por: Sruamsiri, Rosarin, et al.
Publicado: (2016)

Association of patient engagement strategies with utilisation and spending for musculoskeletal problems in the USA: a cross-sectional analysis of Medicare patients and physician practices
por: Brown, Timothy T, et al.
Publicado: (2021)

A Review of the First Year of Medicare Coverage of Erythropoietin
por: Griffiths, Robert I., et al.
Publicado: (1994)

Impact of public-funded health insurances in India on health care utilisation and financial risk protection: a systematic review
por: Reshmi, Bhageerathy, et al.
Publicado: (2021)

Estimating the Cost of a Medicare Outpatient Prescription Drug Benefit
por: Waldo, Daniel R.
Publicado: (1994)

Coverage of New Drugs in Medicare Part D
por: NACI, HUSEYIN, et al.
Publicado: (2022)

MCBS Highlights: Prescription Drug Coverage Among Medicare Beneficiaries
por: Regan, Joseph F., et al.
Publicado: (2007)

The impact of Medicare prescription drug coverage on the use of antidementia drugs
por: Fowler, Nicole R, et al.
Publicado: (2013)

Does Closing the Donut Hole Reduce Financial Burdens Among Medicare Part D Beneficiaries?
por: Zhang, Yalu, et al.
Publicado: (2021)

Prescribing trends of proton pump inhibitors, antipsychotics and benzodiazepines of medicare part d providers
por: Toth, Jennifer M., et al.
Publicado: (2022)

The Center for Medicare and Medicaid Innovation: The Case for Reform
por: Badger, Doug
Publicado: (2022)

Medicare Must Provide Additional Cost and Access Information to Enhance Decision Making Around Trade Offs Between Medicare Advantage and Medigap
por: Grabert, Lisa M.
Publicado: (2022)

The Financial Effect of Medicare Coverage Design and Safety Net Options for Cancer Care
por: Bethay, Stephanie S., et al.
Publicado: (2020)

Impact of repeated hospital accreditation surveys on quality and reliability, an 8-year interrupted time series analysis
por: Devkaran, Subashnie, et al.
Publicado: (2019)

The High Coverage of Dental, Vision, and Hearing Benefits Among Medicare Advantage Enrollees
por: Willink, Amber
Publicado: (2019)

Costs of breast cancer care in Mexico: analysis of two insurance coverage scenarios
por: González-Robledo, María Cecilia, et al.
Publicado: (2015)

Correlation of antimicrobial prescription rate and county income in medicare part D
por: Volpi, Connor, et al.
Publicado: (2019)

Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program
por: Socal, Mariana P., et al.
Publicado: (2021)

The impact of economic austerity and prosperity events on suicide in Greece: a 30-year interrupted time-series analysis
por: Branas, Charles C, et al.
Publicado: (2015)

Impact of rural Family Physician programme on maternal and child health indicators in Iran: an interrupted time series analysis
por: Jabbari Beyrami, Hossein, et al.
Publicado: (2019)

Impact of the consumption tax rate increase on out-of-hospital cardiac arrest in Japan: an interrupted time series analysis
por: Onozuka, Daisuke, et al.
Publicado: (2019)

Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study
por: Hsu, Jason C, et al.
Publicado: (2020)

Trends in the prescription of benzodiazepines for the elderly in Korea
por: Hwang, Soo-Hee, et al.
Publicado: (2017)

Regional Variation in Pharmacist Perception of the Financial Impact of Medicare Part D
por: Khan, Shamima, et al.
Publicado: (2018)

Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
por: Shaw, Daniel L., et al.
Publicado: (2018)

Medicare Part D Coverage Gap Discount Program Beginning in 2011
por: Cahill, Judith A.
Publicado: (2010)

Impact of China’s healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study
por: Zhu, Dawei, et al.
Publicado: (2019)

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study
por: Guan, Xiaodong, et al.
Publicado: (2019)

Impacts of adjustment of National Reimbursement Drug List on orphan drugs volume and spending in China: an interrupted time series analysis
por: Yi, Hongbin, et al.
Publicado: (2023)

The Australian primary healthcare experiment: a national survey of Medicare Locals
por: Robinson, Suzanne, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ve6o5cphvsii0g2asg9bpgj5ks